AAAAAA

   
Results: 1-9 |
Results: 9
PRIMARY AND SECONDARY MYELODYSPLASTIC SYNDROMES IN CHILDHOOD
Authors: PANAGIOTOU JP POLYCHRONOPOULOU S PARCHARIDOU A PAPADAKIS V ANAGNOSTOU D HAIDAS S
Citation: Jp. Panagiotou et al., PRIMARY AND SECONDARY MYELODYSPLASTIC SYNDROMES IN CHILDHOOD, British Journal of Haematology, 102(1), 1998, pp. 344-345
EXCESSIVE PROLIFERATION MATCHED BY EXCESSIVE APOPTOSIS IN MYELODYSPLASTIC SYNDROMES - THE CAUSE-EFFECT RELATIONSHIP
Authors: RAZA A ALVI S BOROK RZ SPAN L PARCHARIDOU A ALSTON D RIFKIN S ROBIN E SHAH R GREGORY SA
Citation: A. Raza et al., EXCESSIVE PROLIFERATION MATCHED BY EXCESSIVE APOPTOSIS IN MYELODYSPLASTIC SYNDROMES - THE CAUSE-EFFECT RELATIONSHIP, Leukemia & lymphoma, 27(1-2), 1997, pp. 111-118
CELL-CYCLE KINETIC-STUDIES IN 68 PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING INTRAVENOUS IODODEOXYURIDINE AND OR BROMODEOXYURIDINE/
Authors: RAZA A ALVI S BROADYROBINSON L SHOWEL M CARTLIDGE J MUNDLE SD SHETTY VT BOROK RZ DAR SE CHOPRA HK SPAN L PARCHARIDOU A HINES C GEZER S VENUGOPAL P LOEW J SHOWEL J ALSTON D HERNANDEZ B RIFKIN S ROBIN E SHAH R GREGORY SA
Citation: A. Raza et al., CELL-CYCLE KINETIC-STUDIES IN 68 PATIENTS WITH MYELODYSPLASTIC SYNDROMES FOLLOWING INTRAVENOUS IODODEOXYURIDINE AND OR BROMODEOXYURIDINE/, Experimental hematology, 25(6), 1997, pp. 530-535
NOVEL INSIGHTS INTO THE BIOLOGY OF MYELODYSPLASTIC SYNDROMES - EXCESSIVE APOPTOSIS AND THE ROLE OF CYTOKINES
Authors: RAZA A MUNDLE S SHETTY V ALVI S CHOPRA H SPAN L PARCHARIDOU A DAR S VENUGOPAL P BOROK R GEZER S SHOWEL J LOEW J ROBIN E RIFKIN S ALSTON D HERNANDEZ B SHAH R KAIZER H GREGORY S
Citation: A. Raza et al., NOVEL INSIGHTS INTO THE BIOLOGY OF MYELODYSPLASTIC SYNDROMES - EXCESSIVE APOPTOSIS AND THE ROLE OF CYTOKINES, International journal of hematology, 63(4), 1996, pp. 265-278
A PARADIGM SHIFT IN MYELODYSPLASTIC SYNDROMES
Authors: RAZA A MUNDLE S SHETTY V ALVI S CHOPRA H SPAN L PARCHARIDOU A DAR S VENUGOPAL P BOROK R GEZER S SHOWEL J LOEW J ROBIN E RIFKIN S ALSTON D HERNANDEZ B SHAH R KAIZER H GREGORY S PREISLER H
Citation: A. Raza et al., A PARADIGM SHIFT IN MYELODYSPLASTIC SYNDROMES, Leukemia, 10(10), 1996, pp. 1648-1652
MEASUREMENT OF APOPTOSIS, PROLIFERATION AND 3 CYTOKINES IN 46 PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: SHETTY V MUNDLE S ALVI S SHOWEL M BROADYROBINSON L DAR S BOROK R SHOWEL J GREGORY S RIFKIN S GEZER S PARCHARIDOU A VENUGOPAL P SHAH R HERNANDEZ B KLEIN M ALSTON D ROBIN E DOMINQUEZ C RAZA A
Citation: V. Shetty et al., MEASUREMENT OF APOPTOSIS, PROLIFERATION AND 3 CYTOKINES IN 46 PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Leukemia research, 20(11-12), 1996, pp. 891-900
EXTENSIVE APOPTOSIS OF BONE-MARROW CELLS AS EVALUATED BY THE IN-SITU END LABELING (ISEL) TECHNIQUE MAY BE THE BASIS FOR INEFFECTIVE HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: PARCHARIDOU A RAZA A ECONOMOPOULOS T PAPAGEORGIOU E ANAGNOSTOU D PAPADAKI T STAMATOPOULOS K RAPTIS S
Citation: A. Parcharidou et al., EXTENSIVE APOPTOSIS OF BONE-MARROW CELLS AS EVALUATED BY THE IN-SITU END LABELING (ISEL) TECHNIQUE MAY BE THE BASIS FOR INEFFECTIVE HEMATOPOIESIS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 86(10), 1995, pp. 3185-3185
APOPTOSIS IN BONE-MARROW BIOPSY SAMPLES INVOLVING STROMAL AND HEMATOPOIETIC-CELLS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES
Authors: RAZA A GEZER S MUNDLE S GAO XZ ALVI S BOROK R RIFKIN S IFTIKHAR A SHETTY V PARCHARIDOU A LOEW J MARCUS B KHAN Z CHANEY C SHOWEL J GREGORY S PREISLER H
Citation: A. Raza et al., APOPTOSIS IN BONE-MARROW BIOPSY SAMPLES INVOLVING STROMAL AND HEMATOPOIETIC-CELLS IN 50 PATIENTS WITH MYELODYSPLASTIC SYNDROMES, Blood, 86(1), 1995, pp. 268-276
ASSESSMENT OF APOPTOSIS IN SERIAL BONE-MARROW (BM) BIOPSIES OF 53 PATIENTS WITH NEWLY-DIAGNOSED HIGH-RISK ACUTE MYELOGENOUS LEUKEMIA (HR-AML) FOLLOWING INDUCTION THERAPY
Authors: PARCHARIDOU A SAIKIA T MUNDLE S SHETTY V SHOTT S KOCHUPILLAI V GREGORY S LOEW J MARCUS B ALVI S LARSON R GOLDBERG J PREISLER H RAZA A
Citation: A. Parcharidou et al., ASSESSMENT OF APOPTOSIS IN SERIAL BONE-MARROW (BM) BIOPSIES OF 53 PATIENTS WITH NEWLY-DIAGNOSED HIGH-RISK ACUTE MYELOGENOUS LEUKEMIA (HR-AML) FOLLOWING INDUCTION THERAPY, Blood, 84(10), 1994, pp. 10000312-10000312
Risultati: 1-9 |